| INTRODUCTION
Laryngeal cancer is the second most common head and neck malignancy, 1 and successful treatment has significant effects on a patient's swallow or voice function. Guidelines state that concomitant chemoradiotherapy (CRT) is the current non-surgical standard of care for T3 laryngeal cancer: CRT should also be considered for those with T4 disease and no spread through cartilage. 2 CRT allows preservation of the laryngeal structures (and hence maintenance of normal voice production), but treatment can have a profoundly adverse effect on swallowing ability. 3 As a result, patients treated with CRT are often dependent on supplementary tube feeding in the short term, with a minority requiring supplementary feeding for more than a year. 4 Patients also have the option of total laryngectomy (TL); this renders the patient a neck breather, with profound consequences for communication. As survival is considered to be similar for the two options, patients are often offered CRT as a first-line therapy, with TL reserved as a salvage procedure in the event of disease recurrence or for patients experiencing laryngeal dysfunction following non-surgical management. Unfortunately, those who receive surgery following radical CRT have a significantly diminished quality of life relative to primary TL, have a far higher rate of fistula formation 5 and often need vascularised flap reconstruction of the surgical defect. 6 Patients will value a "health state" such as life after CRT or TL depending on the priorities they place on their appearance, voice or swallow function. Several methods have previously been used to measure how patients value health states, with the majority of these methods generating a "health utility." Specifically, health utility represents the value placed on a health state and for convenience is anchored between zero (valuing the health state the same as death) and one (valuing the health state the same as normal or full health).
These utility values are mostly found in health economics literature and cost-effectiveness analyses, 7 but are also useful in modelling decision processes. The estimation of utility values draws on a "normative theory" of decision-making, based on the philosophy that under ideal conditions, an individual will make the choice with the maximum expected utility: this is arguably not a reflection of the real-life process of decision-making for patient or clinician. 8 However, they provide a useful insight into the trade-offs which patients with head and neck cancer face when choosing treatment modalities.
Locally advanced laryngeal cancer often provides the clinician and patient with a difficult choice, trading off differences in appearance, speech, swallow and survival. McNeil et al. 9 reported that healthy volunteers would sacrifice survival to maintain a "normal"
voice, but their sample of firemen and middle managers was not representative of the head and neck cancer population. We repeated
McNeil's study on a large sample of patients with chronic obstructive pulmonary disease (COPD), deemed more representative of patients with head and neck cancer. Among the COPD sample, 38%
reported that they would prefer to have a TL. Also, the utility values assigned to the various health states confirmed that the functional quality of the outcomes of treatment was of more importance than the modality. 10 Hence, it could be concluded that a blanket application of the current non-surgical standard of care does not reflect the treatment that patients might choose based on their preferences.
Here, we aimed to investigate this observation further, by interrogating populations with experience of the disease. We performed the same time trade-off experiment on patients with head and neck cancer and the health professionals who treat them, allowing comparison between the two.
2 | ME TH ODS 
| Participants
Two groups of participants were recruited from two head and neck cancer clinics in the north-east of England:
• Group 1-Patients with head and neck cancer: all patient participants had previously received treatment for head and neck cancer of any site and stage and had no evidence of active disease.
• Group 2-Head and neck cancer health professionals: the health professional participants were all involved in the treatment of patients with head and neck cancer, either as part of the multidisciplinary team, on the ward or in the outpatient clinic.
| Study design
Four health state descriptors were developed depicting the treatment process and outcome for CRT optimal outcome, CRT with complications, TL optimal outcome and TL with complications (see 
Keypoints
• The value that an individual places on a health outcome or complication effects the decisions that they make and is of central importance in surgical consent.
• Almost two thirds of patients and healthcare staff would choose chemoradiotherapy to treat advanced laryngeal cancer, the others choosing total laryngectomy.
• Staff members consistently assigned a higher utility value to the health states experienced after treatment for advanced laryngeal cancer than the patients they treat.
• There was notable variation in the value placed on the health states between individual staff members and patients.
• Decision making pathways should be designed to allow these individual variation in values and preferences to guide decision making in order to deliver patient-centred care.
carry out three exercises. In exercise one, participants ranked the four available health states alongside their own health from most to least desirable. In exercise two, participants were offered a choice between alternative 1 (to remain in one of the health states for 10 years) and alternative 2 (to retain normal health, but with a decreased survival [x years]). X was varied until the respondent became indifferent between the two alternatives, at which point the utility value for that health state was derived. 11, 12 For example, a participant who felt 10 years with a laryngectomy was equivalent to 7 years in their normal health state yields a laryngectomy utility value of 7/10=0.7. Each of the four health states was presented similarly, in a random order to control for order of study bias. 11 If the participant was under 45 years old, 25 years was used as the basis of the survival scale (with 2.5 year increments); however, the utility values were generated in the same manner regardless of age. During exercise three, the participant was asked again which of the two optimal outcome health states they would prefer: total laryngectomy optimal outcome or chemoradiotherapy optimal outcome. The years of survival associated with the non-preferred option were then increased (using a similar technique to the time trade-off exercise) to determine the number of years of survival advantage, if any, that would lead to a change in decision.
| Statistical methods
Average utility value scores were non-normally distributed and compared using Mann-Whitney test. All statistical calculations were per- 
| RESULTS
A total of 49 patients and 73 staff members took part in this study (see Table 1 ). All participants were able to complete all three exercises.
| Ranking exercise
When given the choice, current health was the preferred health state for all staff participants (see Figure 1) 
| Utility values
There was noticeable variability in the range of responses regarding the utility values (see Figure 2) . The average assigned utility value for each health state is shown in Figure 3 . Staff members consistently rated the post-treatment health states higher than the patient group. The difference between the optimal outcome and outcome with complications was also more marked for the patient group than it was for the staff group. For both groups, CRT optimal outcome was assigned the highest utility value (0.77 for staff members, 0.73 for patients) and CRT poor outcome had the lowest utility value (0.49 for staff members and 0.36 for patients). The difference in mean utility value was not significant between staff and patient participants for any of the health states apart from CRT with complications (P=.026).
| Survival advantage
The 
| Comparisons with other studies
To make a decision on behalf of a patient, a clinician may assume that tage. In contrast, non-patients, oncology doctors and nurses were much less likely to opt for such a treatment with the expectation of minimal gain. 17 Decision-making in health care is driven by the value that a particular individual (professional or patient) places on health states and intervention risks. Indeed, these values often have more of an effect on the decision made than the severity of the symptom itself.
Barry et al. 18 found that patient-reported symptom severity in prostate disease did sufficiently explain which patients chose to go ahead with surgical intervention. The most important indicator of the treatment chosen was how bothersome (rather than necessarily severe) the symptoms were, and how patients' attitudes varied towards the complications of surgery (eg the prospect of sexual dysfunction): those patients who were "bothered" were seven times more likely to opt for surgery. In the same way, although objective pain scores were a predictor of time to knee replacement in patients with osteoarthritis, a willingness to undergo surgery or preference for surgery had a greater effect on the choice made. conflict, a decreased proportion of patients who were passive in decision-making and fewer patients remaining undecided. There was also a reported increase in patient satisfaction with the decisionmaking encounter and improved perception of risk. 22 However, it must not be assumed that the presence of a decision aid ensures shared decision-making is taking place 23 : for this to happen, both individual, system-wide and cultural attitudes must support the process. 24 Nevertheless, we have demonstrated here and previously cancer, methods of providing information and eliciting treatmentrelated values must be central to the decision-making process. 
